Atazanavir Sulfate

Product NDC: 65862-713
11-digit product format: 658620713
Labeler code: 65862
Product ID: 65862-713_8f8c56e0-40ee-4643-88f7-d3571ff5a409
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Atazanavir
Dosage form: CAPSULE
Route: ORAL
Labeler: Aurobindo Pharma Limited
Application: ANDA204806
Marketing category: ANDA
Marketing start: 2018-06-25
Substance: ATAZANAVIR SULFATE
Active strength: 300 mg/1
Pharmacologic classes: Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], HIV Protease Inhibitors [MoA], Protease Inhibitor [EPC], UDP Glucuronosyltransferases Inhibitors [MoA], UGT1A1 Inhibitors [MoA]
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
unfinished product	product	65862-713		UNFINISHED	Active or certified unfinished drug listing		2026-08-03
unfinished package	package	65862-713	65862-713-15	UNFINISHED	Active or certified unfinished drug listing		2026-08-03

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 40 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 21:27 UTC · source 2025-12-05	unfinished product	product		`a6255e0c9aa5…`	`a0211a219f2e…`
2025-12-14 21:27 UTC · source 2025-12-05	unfinished package	package	65862-713-15	`a6255e0c9aa5…`	`a0211a219f2e…`
2025-08-26 23:59 UTC · source 2025-08-26	unfinished product	product		`1d862106b807…`	`00c93037cd84…`
2025-08-26 23:59 UTC · source 2025-08-26	unfinished package	package	65862-713-15	`1d862106b807…`	`00c93037cd84…`
2025-05-15 14:59 UTC · source 2025-05-14	unfinished product	product		`390b4c401c3f…`	`2c692c2daee3…`
2025-05-15 14:59 UTC · source 2025-05-14	unfinished package	package	65862-713-15	`390b4c401c3f…`	`2c692c2daee3…`
2025-04-01 07:37 UTC · source 2025-03-31	unfinished product	product		`e30019b0c005…`	`a3f0b14938b7…`
2025-04-01 07:37 UTC · source 2025-03-31	unfinished package	package	65862-713-15	`e30019b0c005…`	`a3f0b14938b7…`
2025-03-01 13:19 UTC · source 2025-02-28	unfinished product	product		`bbbc9f937eca…`	`946b9c97cf81…`
2025-03-01 13:19 UTC · source 2025-02-28	unfinished package	package	65862-713-15	`bbbc9f937eca…`	`946b9c97cf81…`
2025-02-27 05:24 UTC · source 2025-02-26	unfinished product	product		`f268b84574a6…`	`26285f5ac5df…`
2025-02-27 05:24 UTC · source 2025-02-26	unfinished package	package	65862-713-15	`f268b84574a6…`	`26285f5ac5df…`
2025-02-01 13:13 UTC · source 2025-01-31	unfinished product	product		`f764e8902f78…`	`92046438deef…`
2025-02-01 13:13 UTC · source 2025-01-31	unfinished package	package	65862-713-15	`f764e8902f78…`	`92046438deef…`
2025-01-20 13:05 UTC · source 2025-01-17	unfinished product	product		`68b1e3bced9e…`	`98a755eb8bc6…`
2025-01-20 13:05 UTC · source 2025-01-17	unfinished package	package	65862-713-15	`68b1e3bced9e…`	`98a755eb8bc6…`
2024-11-29 20:42 UTC · source 2024-11-29	unfinished product	product		`05c55d027831…`	`ca05dca9dc4c…`
2024-11-29 20:42 UTC · source 2024-11-29	unfinished package	package	65862-713-15	`05c55d027831…`	`ca05dca9dc4c…`
2024-11-09 02:36 UTC · source 2024-11-08	unfinished product	product		`48b4f40e6753…`	`c7c7a00d2afa…`
2024-11-09 02:36 UTC · source 2024-11-08	unfinished package	package	65862-713-15	`48b4f40e6753…`	`c7c7a00d2afa…`
2024-10-09 02:27 UTC · source 2024-10-08	unfinished product	product		`27f29a85d7e4…`	`1372111e901f…`
2024-10-09 02:27 UTC · source 2024-10-08	unfinished package	package	65862-713-15	`27f29a85d7e4…`	`1372111e901f…`
2024-07-10 04:00 UTC · source 2024-07-09	unfinished product	product		`8d62ce987f31…`	`9fe9ef23e30d…`
2024-07-10 04:00 UTC · source 2024-07-09	unfinished package	package	65862-713-15	`8d62ce987f31…`	`9fe9ef23e30d…`
2024-05-28 21:11 UTC · source 2024-05-28	unfinished product	product		`d1e113ab4d42…`	`063ee3eb0a1d…`
2024-05-28 21:11 UTC · source 2024-05-28	unfinished package	package	65862-713-15	`d1e113ab4d42…`	`063ee3eb0a1d…`
2024-05-15 03:51 UTC · source 2024-05-14	unfinished product	product		`50b4072663b7…`	`eae3003ed65e…`
2024-05-15 03:51 UTC · source 2024-05-14	unfinished package	package	65862-713-15	`50b4072663b7…`	`eae3003ed65e…`
2022-04-09 23:13 UTC · source 2022-04-08	unfinished product	product		`906f6e251498…`	`bf70b80e44f0…`
2022-04-09 23:13 UTC · source 2022-04-08	unfinished package	package	65862-713-15	`906f6e251498…`	`bf70b80e44f0…`
2021-12-27 23:28 UTC · source 2021-12-27	unfinished product	product		`6db9cb8d1e19…`	`3449e1ec5b70…`
2021-12-27 23:28 UTC · source 2021-12-27	unfinished package	package	65862-713-15	`6db9cb8d1e19…`	`3449e1ec5b70…`
2021-02-18 23:40 UTC · source 2021-02-18	unfinished product	product		`8fc7167e32ce…`	`e96bbc724034…`
2021-02-18 23:40 UTC · source 2021-02-18	unfinished package	package	65862-713-15	`8fc7167e32ce…`	`e96bbc724034…`
2020-12-18 03:04 UTC · source 2020-12-17	unfinished product	product		`4184dd79f89f…`	`545327b3e20f…`
2020-12-18 03:04 UTC · source 2020-12-17	unfinished package	package	65862-713-15	`4184dd79f89f…`	`545327b3e20f…`
2020-06-10 20:45 UTC · source 2020-06-10	unfinished product	product		`4bd3596a7b87…`	`5c64c6f6865f…`
2020-06-10 20:45 UTC · source 2020-06-10	unfinished package	package	65862-713-15	`4bd3596a7b87…`	`5c64c6f6865f…`
2019-12-08 06:16 UTC · source 2019-12-05	unfinished product	product		`263afe128892…`	`91768de4ddbe…`
2019-12-08 06:16 UTC · source 2019-12-05	unfinished package	package	65862-713-15	`263afe128892…`	`91768de4ddbe…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 4 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	Approval date
A204806-001	ATAZANAVIR SULFATE	ATAZANAVIR SULFATE	EQ 100MG BASE	CAPSULE / ORAL	AB	2018-06-25
A204806-002	ATAZANAVIR SULFATE	ATAZANAVIR SULFATE	EQ 150MG BASE	CAPSULE / ORAL	AB	2018-06-25
A204806-003	ATAZANAVIR SULFATE	ATAZANAVIR SULFATE	EQ 200MG BASE	CAPSULE / ORAL	AB	2018-06-25
A204806-004	ATAZANAVIR SULFATE	ATAZANAVIR SULFATE	EQ 300MG BASE	CAPSULE / ORAL	AB	2018-06-25

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 4 matching rows.

Application-product, TE code table
Application-product	TE code
A204806-001	AB
A204806-002	AB
A204806-003	AB
A204806-004	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 5 · 164 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A204806-001	ATAZANAVIR SULFATE	EQ 100MG BASE	CAPSULE / ORAL	AB	2018-06-25	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A204806-002	ATAZANAVIR SULFATE	EQ 150MG BASE	CAPSULE / ORAL	AB	2018-06-25	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A204806-003	ATAZANAVIR SULFATE	EQ 200MG BASE	CAPSULE / ORAL	AB	2018-06-25	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A204806-004	ATAZANAVIR SULFATE	EQ 300MG BASE	CAPSULE / ORAL	AB	2018-06-25	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A204806-001	ATAZANAVIR SULFATE	EQ 100MG BASE	CAPSULE / ORAL	AB	2018-06-25	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A204806-002	ATAZANAVIR SULFATE	EQ 150MG BASE	CAPSULE / ORAL	AB	2018-06-25	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A204806-003	ATAZANAVIR SULFATE	EQ 200MG BASE	CAPSULE / ORAL	AB	2018-06-25	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A204806-004	ATAZANAVIR SULFATE	EQ 300MG BASE	CAPSULE / ORAL	AB	2018-06-25	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A204806-001	ATAZANAVIR SULFATE	EQ 100MG BASE	CAPSULE / ORAL	AB	2018-06-25	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A204806-002	ATAZANAVIR SULFATE	EQ 150MG BASE	CAPSULE / ORAL	AB	2018-06-25	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A204806-003	ATAZANAVIR SULFATE	EQ 200MG BASE	CAPSULE / ORAL	AB	2018-06-25	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A204806-004	ATAZANAVIR SULFATE	EQ 300MG BASE	CAPSULE / ORAL	AB	2018-06-25	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A204806-001	ATAZANAVIR SULFATE	EQ 100MG BASE	CAPSULE / ORAL	AB	2018-06-25	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A204806-002	ATAZANAVIR SULFATE	EQ 150MG BASE	CAPSULE / ORAL	AB	2018-06-25	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A204806-003	ATAZANAVIR SULFATE	EQ 200MG BASE	CAPSULE / ORAL	AB	2018-06-25	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A204806-004	ATAZANAVIR SULFATE	EQ 300MG BASE	CAPSULE / ORAL	AB	2018-06-25	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A204806-001	ATAZANAVIR SULFATE	EQ 100MG BASE	CAPSULE / ORAL	AB	2018-06-25	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A204806-002	ATAZANAVIR SULFATE	EQ 150MG BASE	CAPSULE / ORAL	AB	2018-06-25	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A204806-003	ATAZANAVIR SULFATE	EQ 200MG BASE	CAPSULE / ORAL	AB	2018-06-25	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A204806-004	ATAZANAVIR SULFATE	EQ 300MG BASE	CAPSULE / ORAL	AB	2018-06-25	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A204806-001	ATAZANAVIR SULFATE	EQ 100MG BASE	CAPSULE / ORAL	AB	2018-06-25	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A204806-002	ATAZANAVIR SULFATE	EQ 150MG BASE	CAPSULE / ORAL	AB	2018-06-25	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A204806-003	ATAZANAVIR SULFATE	EQ 200MG BASE	CAPSULE / ORAL	AB	2018-06-25	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A204806-004	ATAZANAVIR SULFATE	EQ 300MG BASE	CAPSULE / ORAL	AB	2018-06-25	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A204806-001	ATAZANAVIR SULFATE	EQ 100MG BASE	CAPSULE / ORAL	AB	2018-06-25	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A204806-002	ATAZANAVIR SULFATE	EQ 150MG BASE	CAPSULE / ORAL	AB	2018-06-25	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A204806-003	ATAZANAVIR SULFATE	EQ 200MG BASE	CAPSULE / ORAL	AB	2018-06-25	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A204806-004	ATAZANAVIR SULFATE	EQ 300MG BASE	CAPSULE / ORAL	AB	2018-06-25	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A204806-001	ATAZANAVIR SULFATE	EQ 100MG BASE	CAPSULE / ORAL	AB	2018-06-25	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A204806-002	ATAZANAVIR SULFATE	EQ 150MG BASE	CAPSULE / ORAL	AB	2018-06-25	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A204806-003	ATAZANAVIR SULFATE	EQ 200MG BASE	CAPSULE / ORAL	AB	2018-06-25	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A204806-004	ATAZANAVIR SULFATE	EQ 300MG BASE	CAPSULE / ORAL	AB	2018-06-25	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A204806-001	ATAZANAVIR SULFATE	EQ 100MG BASE	CAPSULE / ORAL	AB	2018-06-25	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A204806-002	ATAZANAVIR SULFATE	EQ 150MG BASE	CAPSULE / ORAL	AB	2018-06-25	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A204806-003	ATAZANAVIR SULFATE	EQ 200MG BASE	CAPSULE / ORAL	AB	2018-06-25	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A204806-004	ATAZANAVIR SULFATE	EQ 300MG BASE	CAPSULE / ORAL	AB	2018-06-25	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A204806-001	ATAZANAVIR SULFATE	EQ 100MG BASE	CAPSULE / ORAL	AB	2018-06-25	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A204806-002	ATAZANAVIR SULFATE	EQ 150MG BASE	CAPSULE / ORAL	AB	2018-06-25	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A204806-003	ATAZANAVIR SULFATE	EQ 200MG BASE	CAPSULE / ORAL	AB	2018-06-25	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A204806-004	ATAZANAVIR SULFATE	EQ 300MG BASE	CAPSULE / ORAL	AB	2018-06-25	`d06236e962d9…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 5 · 164 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A204806-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A204806-002	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A204806-003	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A204806-004	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A204806-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A204806-002	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A204806-003	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A204806-004	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A204806-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A204806-002	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A204806-003	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A204806-004	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A204806-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A204806-002	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A204806-003	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A204806-004	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A204806-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A204806-002	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A204806-003	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A204806-004	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A204806-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A204806-002	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A204806-003	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A204806-004	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A204806-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A204806-002	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A204806-003	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A204806-004	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A204806-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A204806-002	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A204806-003	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A204806-004	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A204806-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A204806-002	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A204806-003	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A204806-004	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A204806-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A204806-002	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A204806-003	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A204806-004	AB	1	`d06236e962d9…`

Additional Listing Data#

Finished product: Yes
Brand name base: Atazanavir Sulfate
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
ATAZANAVIR SULFATE	300 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
4MT4VIE29P	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 4 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
402245	Internal RxNorm lookup
402246	Internal RxNorm lookup
402247	Internal RxNorm lookup
664741	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
7fbea274-d6b5-4faa-bbf0-05fefab42114	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
7bc938bd-f454-36ec-72ed-9ef05424b276	Product name	8	20221117
248d7995-abf1-4569-b3c6-f9ebc230e8ef	Product name	1	20150323

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
65862-713-03	Atazanavir Sulfate	3 in 1 CARTON	CAPSULE	3	8
65862-713-05	Atazanavir Sulfate	500 in 1 BOTTLE	CAPSULE	500	8
65862-713-10	Atazanavir Sulfate	10 in 1 BLISTER PACK	CAPSULE	10	8
65862-713-30	Atazanavir Sulfate	30 in 1 BOTTLE	CAPSULE	30	8
65862-713-90	Atazanavir Sulfate	90 in 1 BOTTLE	CAPSULE	90	8

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
65862-713-30	EA - Each	65862-713	8b014119-5b8e-4c7e-9142-ebab5419b0b1	1	2018-07-03

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
65862-713	ATAZANAVIR SULFATE (ATAZANAVIR) CAPSULE [AUROBINDO PHARMA LIMITED]	7	Current NDC, Legacy NDC, 5 package rows	20250206_7fbea274-d6b5-4faa-bbf0-05fefab42114.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Atazanavir Sulfate	ATAZANAVIR	Aurobindo Pharma Limited	7fbea274-d6b5-4faa-bbf0-05fefab42114	2025-08-06	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 204806 application number: ANDA204806 ndc (product): 65862-713

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
4MT4VIE29P	ATAZANAVIR SULFATE	229975-97-7	ATAZANAVIR SULFATE
QZU4H47A3S	ATAZANAVIR	198904-31-3	Atazanavir

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
402245	atazanavir sulfate 100 MG Oral Capsule	PSN	7fbea274-d6b5-4faa-bbf0-05fefab42114	8
402246	atazanavir sulfate 150 MG Oral Capsule	PSN	7fbea274-d6b5-4faa-bbf0-05fefab42114	8
402247	atazanavir sulfate 200 MG Oral Capsule	PSN	7fbea274-d6b5-4faa-bbf0-05fefab42114	8
664741	atazanavir sulfate 300 MG Oral Capsule	PSN	7fbea274-d6b5-4faa-bbf0-05fefab42114	8
402245	atazanavir 100 MG Oral Capsule	SCD	7fbea274-d6b5-4faa-bbf0-05fefab42114	8
402246	atazanavir 150 MG Oral Capsule	SCD	7fbea274-d6b5-4faa-bbf0-05fefab42114	8
402247	atazanavir 200 MG Oral Capsule	SCD	7fbea274-d6b5-4faa-bbf0-05fefab42114	8
664741	atazanavir 300 MG Oral Capsule	SCD	7fbea274-d6b5-4faa-bbf0-05fefab42114	8
402245	atazanavir 100 MG (as atazanavir sulfate 113.9 MG) Oral Capsule	SY	7fbea274-d6b5-4faa-bbf0-05fefab42114	8
402246	atazanavir 150 MG (as atazanavir sulfate 170.8 MG) Oral Capsule	SY	7fbea274-d6b5-4faa-bbf0-05fefab42114	8
402247	atazanavir 200 MG (as atazanavir sulfate 227.8 MG) Oral Capsule	SY	7fbea274-d6b5-4faa-bbf0-05fefab42114	8
664741	atazanavir 300 MG (as atazanavir sulfate 341.69 MG) Oral Capsule	SY	7fbea274-d6b5-4faa-bbf0-05fefab42114	8

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
65862-713-03	65862071303	3 BLISTER PACK in 1 CARTON (65862-713-03) / 10 CAPSULE in 1 BLISTER PACK (65862-713-10)	3 blister pack	2018-06-25	0000-00-00	No	No	Current
65862-713-05	65862071305	500 CAPSULE in 1 BOTTLE (65862-713-05)	500 capsule	2018-06-25	0000-00-00	No	No	Current
65862-713-10	65862071310	10 in 1 BLISTER PACK						Historical
65862-713-15	65862071315	1500 CAPSULE in 1 BAG (65862-713-15)	1500 capsule	25-JUN-18				Current
65862-713-30	65862071330	30 CAPSULE in 1 BOTTLE (65862-713-30)	30 capsule	2018-06-25	0000-00-00	No	No	Current
65862-713-90	65862071390	90 CAPSULE in 1 BOTTLE (65862-713-90)	90 capsule	2018-06-25	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Atazanavir Sulfate	Aurobindo Pharma Limited	2025-08-06	Human Prescription Drug Label	8
Atazanavir Sulfate	REMEDYREPACK INC.	2022-07-15	HUMAN PRESCRIPTION DRUG LABEL	6
Atazanavir Sulfate	Major Pharmaceuticals \| Nutra-Med Packaging, Inc.	2021-12-13	HUMAN PRESCRIPTION DRUG LABEL	2
Atazanavir Sulfate	American Health Packaging	2019-04-12	HUMAN PRESCRIPTION DRUG LABEL	2